FDA OTC Drugs Of Abuse Screening Kit Guide Clarifies Cost Bundling
This article was originally published in The Tan Sheet
Executive Summary
FDA does not advise that OTC device manufacturers bundle the cost of primary and confirmation tests for home-use drugs of abuse test kits, the agency states in a draft guidance published in the Federal Register Dec. 2